You just read:

Yisheng Biopharma Receives IND Clearance from China NMPA to Initiate Clinical Trial of YS-ON-001 in the Treatment of Advanced Solid Tumors

News provided by

Yisheng Biopharma Co., Ltd.

Jun 26, 2019, 21:00 ET